TRML – tourmaline bio, inc. (US:NASDAQ)
Stock Stats
News
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at Wedbush from $42.00 to $43.00. They now have an "outperform" rating on the stock.
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at HC Wainwright from $49.00 to $50.00. They now have a "buy" rating on the stock.
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Tourmaline Bio, Inc. (NASDAQ: TRML) is now covered by analysts at Wedbush. They set an "outperform" rating and a $42.00 price target on the stock.
Tourmaline Bio to Present at the Leerink Partners Global Healthcare Conference 2025
Form S-8 Tourmaline Bio, Inc.
Form 10-K Tourmaline Bio, Inc. For: Dec 31
Form 8-K Tourmaline Bio, Inc. For: Mar 13
Form SCHEDULE 13G/A Tourmaline Bio, Inc. Filed by: Blue Owl Capital Holdings LP
Form 4 Tourmaline Bio, Inc. For: Feb 03 Filed by: Kulkarni Sandeep Chidambar
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.